Armata Pharmaceuticals, Inc.ARMPNYSE
Loading
SG&A Expenses Over TimeStrong
Percentile Rank93
3Y CAGR+17.4%
5Y CAGR+8.6%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+17.4%/yr
vs +6.9%/yr prior
5Y CAGR
+8.6%/yr
Recent acceleration
Acceleration
+10.6pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$12.04M-8.7%
2024$13.18M+23.5%
2023$10.68M+43.6%
2022$7.44M-10.2%
2021$8.28M+4.0%
2020$7.97M+0.7%
2019$7.91M+38.8%
2018$5.70M-24.9%
2017$7.59M-9.8%
2016$8.41M-